Corvus Pharmaceuticals (CRVS) EPS (Basic) (2015 - 2026)
Corvus Pharmaceuticals (CRVS) posted quarterly EPS (Basic) of -$0.15 for Q1 2026, down 166.7% year-over-year from $0.22 in Q1 2025, and down 22.55% quarter-over-quarter from -$0.12 in Q3 2025.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) EPS (Basic) (2015 - 2026) Analysis & Trends
Corvus Pharmaceuticals' EPS (Basic) history runs 12 years deep, the most recent figure standing at -$0.15 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 166.7% year-over-year to -$0.15; the TTM figure through Mar 2026 stood at -$0.34 (up 10.97% YoY), while the FY2025 annual figure was -$1.29, up 12.9% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.15, down from -$0.12 in the prior quarter.
- The five-year high for EPS (Basic) was $0.22 in Q1 2025, with the low at -$0.59 in Q3 2024.
- The 5-year median for EPS (Basic) is -$0.12 (2024), against an average of -$0.14.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) sank 465.26% in 2024, then soared 280.16% in 2025.
- Corvus Pharmaceuticals' EPS (Basic) stood at -$0.12 in 2022, then grew by 3.84% to -$0.12 in 2023, then tumbled by 396.61% to -$0.59 in 2024, then surged by 79.97% to -$0.12 in 2025, then declined by 22.55% to -$0.15 in 2026.
- Business Quant data shows CRVS's EPS (Basic) at -$0.15 in Q1 2026, -$0.12 in Q3 2025, and -$0.1 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Corvus Pharmaceuticals | 1.35 Bn | 1.14 Bn | - | -0.19 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.19 |
| Mar 31, 2026 | -0.15 |
| Sep 30, 2025 | -0.12 |
| Jun 30, 2025 | -0.10 |
| Mar 31, 2025 | 0.22 |
| Sep 30, 2024 | -0.59 |
| Jun 30, 2024 | -0.06 |
| Mar 31, 2024 | -0.12 |
| Dec 31, 2023 | -0.11 |
| Sep 30, 2023 | -0.10 |
| Jun 30, 2023 | -0.11 |
| Mar 31, 2023 | -0.13 |
| Dec 31, 2022 | -0.11 |
| Sep 30, 2022 | -0.26 |
| Jun 30, 2022 | -0.15 |
| Mar 31, 2022 | -0.16 |
| Dec 31, 2021 | -0.16 |
| Sep 30, 2021 | -0.21 |
| Jun 30, 2021 | -0.27 |
| Mar 31, 2021 | -0.33 |